MARKET

AEZS

AEZS

Aeterna Zentaris
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.4360
+0.0020
+0.46%
After Hours: 0.4349 -0.0011 -0.25% 19:58 07/10 EDT
OPEN
0.4337
PREV CLOSE
0.4340
HIGH
0.4540
LOW
0.4211
VOLUME
3.88M
TURNOVER
--
52 WEEK HIGH
2.835
52 WEEK LOW
0.3697
MARKET CAP
10.28M
P/E (TTM)
-19.5516
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AEZS stock price target is 4.500 with a high estimate of 4.500 and a low estimate of 4.500.

EPS

AEZS News

More
Mid-Afternoon Market Update: Nasdaq Rises 0.8%; Intersect ENT Shares Spike Higher
Toward the end of trading Wednesday, the Dow traded up 0.09% to 25912.45 while the NASDAQ rose 0.80% to 10,426.66. The S&P also rose, gaining 0.21% to 3,151.79.
Benzinga · 4d ago
30 Stocks Moving in Wednesday's Pre-Market Session
Gainers Party City Holdco Inc. (NYSE: PRTY) rose 34.4% to $1.74 in pre-market trading after the company announced it regained compliance with NYSE continued listing standards.
Benzinga · 4d ago
65 Biggest Movers From Yesterday
Gainers MOGU Inc. (NASDAQ: MOGU) shares climbed 104.8% to close at $5.92 on Tuesday.
Benzinga · 4d ago
AETERNA ZENTARIS ANNOUNCES CLOSING OF $12 MILLION PUBLIC OFFERING
GlobeNewswire · 5d ago
51 Stocks Moving In Tuesday's Mid-Day Session
Gainers
Benzinga · 5d ago
36 Stocks Moving in Tuesday's Pre-Market Session
Gainers Endologix, Inc. (NASDAQ: ELGX) rose 104.8% to $0.5187 in pre-market trading. Endologix shares dipped 67% on Monday after the company said it has initiated a voluntary Chapter 11 filing after undergoing a strategic review.
Benzinga · 5d ago
66 Biggest Movers From Thursday
Gainers GEE Group, Inc. (NYSE: JOB) shares climbed 199.9% to close at $1.54 on Thursday after the company eliminated over $47 million in debt and mezzanine financing.
Benzinga · 6d ago
Is Aeterna Zentaris (TSE:AEZS) In A Good Position To Deliver On Growth Plans?
Simply Wall St. · 07/03 12:12

Industry

Biotechnology & Medical Research
-0.39%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Symbol
Price
%Change

About AEZS

Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others. The Company's principal product candidates are Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The Company focuses on its product candidates Zoptrex and Macrilen, which are in Phase III clinical development, and on a luteinizing hormone-releasing hormone (LHRH)-disorazol Z conjugate (AEZS-138), which is in pre-clinical development in oncology and is available for partnering. The Company's direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc.
More

Webull offers kinds of AEterna Zentaris Inc. (USA) stock information, including NASDAQ:AEZS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AEZS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AEZS stock methods without spending real money on the virtual paper trading platform.